We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
TriLink Biotechnologies Announces Supplier Agreement with Applied Biosystems
News

TriLink Biotechnologies Announces Supplier Agreement with Applied Biosystems

TriLink Biotechnologies Announces Supplier Agreement with Applied Biosystems
News

TriLink Biotechnologies Announces Supplier Agreement with Applied Biosystems

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "TriLink Biotechnologies Announces Supplier Agreement with Applied Biosystems"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

TriLink Biotechnologies announced that it has signed a service agreement with Applied Biosystems to supply reagents for Applied Biosystems' recently launched next-generation genetic analysis platform, the SOLiD™ System.

As part of the agreement, TriLink is providing Applied Biosystems with custom dye-labeled oligonucleotides, or chemically synthesized nucleotides, which are used as part of the DNA sequencing process.

"Working with best-in-class suppliers like TriLink has enabled us to develop the most robust, accurate, and highest-throughput genetic analysis platform available to help our customers take advantage of the emerging applications for next-generation DNA sequencing," said Kim Caple, vice president and general manager for Applied Biosystems' next-generation sequencing business.

"We are proud that Applied Biosystems has chosen TriLink to be the supplier of the oligonucleotides used in the SOLiD™ system," said TriLink CEO, Dr. Richard Hogrefe.

Advertisement